BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20881513)

  • 1. CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzyme.
    Browning SL; Tarekegn A; Bekele E; Bradman N; Thomas MG
    Pharmacogenet Genomics; 2010 Nov; 20(11):647-64. PubMed ID: 20881513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of linkage disequilibrium patterns and haplotype structure of eight single nucleotide polymorphisms across the CYP1A2 gene between the Korean, and other populations registered in the International HapMap database.
    Woo SW; Kang TS; Park HJ; Lee JE; Roh J
    J Clin Pharm Ther; 2009 Aug; 34(4):429-36. PubMed ID: 19583676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of CYP1A2, novel polymorphisms and haplotypes in three distinct Asian populations.
    Lim JS; Singh O; Ramasamy RD; Ramasamy S; Subramanian K; Lee EJ; Chowbay B
    Drug Metab Pharmacokinet; 2010; 25(6):616-23. PubMed ID: 20930417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
    Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
    Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection.
    Wooding SP; Watkins WS; Bamshad MJ; Dunn DM; Weiss RB; Jorde LB
    Am J Hum Genet; 2002 Sep; 71(3):528-42. PubMed ID: 12181774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.
    Soyama A; Saito Y; Hanioka N; Maekawa K; Komamura K; Kamakura S; Kitakaze M; Tomoike H; Ueno K; Goto Y; Kimura H; Katoh M; Sugai K; Saitoh O; Kawai M; Ohnuma T; Ohtsuki T; Suzuki C; Minami N; Kamatani N; Ozawa S; Sawada J
    Drug Metab Pharmacokinet; 2005 Feb; 20(1):24-33. PubMed ID: 15770072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.
    Jiang Z; Dragin N; Jorge-Nebert LF; Martin MV; Guengerich FP; Aklillu E; Ingelman-Sundberg M; Hammons GJ; Lyn-Cook BD; Kadlubar FF; Saldana SN; Sorter M; Vinks AA; Nassr N; von Richter O; Jin L; Nebert DW
    Pharmacogenet Genomics; 2006 May; 16(5):359-67. PubMed ID: 16609368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
    Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
    Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.
    Gunes A; Dahl ML
    Pharmacogenomics; 2008 May; 9(5):625-37. PubMed ID: 18466106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
    Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
    Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study.
    Geng T; Zhang XY; Wang L; Wang H; Shi X; Kang L; Hou P; Jin T
    Xenobiotica; 2016; 46(6):542-7. PubMed ID: 26383175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethiopian genetic diversity reveals linguistic stratification and complex influences on the Ethiopian gene pool.
    Pagani L; Kivisild T; Tarekegn A; Ekong R; Plaster C; Gallego Romero I; Ayub Q; Mehdi SQ; Thomas MG; Luiselli D; Bekele E; Bradman N; Balding DJ; Tyler-Smith C
    Am J Hum Genet; 2012 Jul; 91(1):83-96. PubMed ID: 22726845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracing the route of modern humans out of Africa by using 225 human genome sequences from Ethiopians and Egyptians.
    Pagani L; Schiffels S; Gurdasani D; Danecek P; Scally A; Chen Y; Xue Y; Haber M; Ekong R; Oljira T; Mekonnen E; Luiselli D; Bradman N; Bekele E; Zalloua P; Durbin R; Kivisild T; Tyler-Smith C
    Am J Hum Genet; 2015 Jun; 96(6):986-91. PubMed ID: 26027499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.
    Ren Y; Liu F; Shi X; Geng T; Yuan D; Wang L; Kang L; Jin T; Chen C
    Mol Med Rep; 2017 Jul; 16(1):573-580. PubMed ID: 28560456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG site degeneration triggered by the loss of functional constraint created a highly polymorphic macaque drug-metabolizing gene, CYP1A2.
    Uno Y; Osada N
    BMC Evol Biol; 2011 Oct; 11():283. PubMed ID: 21961956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1.
    Mekonnen E; Bekele E
    PLoS One; 2017; 12(10):e0184931. PubMed ID: 28981537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome.
    Conrad DF; Jakobsson M; Coop G; Wen X; Wall JD; Rosenberg NA; Pritchard JK
    Nat Genet; 2006 Nov; 38(11):1251-60. PubMed ID: 17057719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 genetic diversity, haplotype structure and production differ in two ethnically distinct South African populations.
    Paximadis M; Picton ACP; Sengupta D; Ramsay M; Puren A; Tiemessen CT
    Cytokine; 2021 Jul; 143():155489. PubMed ID: 33814271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population.
    Matakova T; Halasova E; Dzian A; Hruby R; Halasa M; Javorka K; Skerenova M
    Adv Exp Med Biol; 2016; 911():23-32. PubMed ID: 26987327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.